|
Dr. Mazanet is presently serving as the CEO of Breakthrough Therapeutics, LLC and as acting CEO of Access Pharmaceuticals (AMEX: AKC). Previously, Dr. Mazanet has served as the CSO and General Partner of Oracle Partners, L.P. and prior to that was the Director of Clinical Research at Amgen, Inc.. In addition, Dr. Mazanet is a member of the Board of Trustees of the University of Pennsylvania School of Medicine and serves on the boards of several public companies including GTx Inc. and Aksys Inc. | 